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In 1990, the majority of patients who undergo cardiac 
catheterization will have the procedure performed in a 
hospital-based catheterization laboratory. Most of these 
patients will be hospitalized for the procedure, but many will 
be outpatients. Thus, the era of outpatient cardiac catheter- 
ization is on us, and I believe it is here to stay. However, I 
also believe that one must clearly differentiate outpatient 
catheterization performed in a hospital facility with surgical 
backup from that performed in a freestanding or a mobile 
cardiac catheterization laboratory with no surgical backup. 
What follows is my own assessment of the situation as it 
stands in early 1990. 
Background. In May 1985, the American College of 
Physicians issued a Clinical Efficacy Assessment Project 
(CEAP) position statement on ambulatory cardiac catheter- 
ization (1). It stated that for certain adult patients with stable 
coronary symptoms, full hospitalization for cardiac catheter- 
ization and angiography might not always be necessary. It 
appeared that these procedures could be safely performed in 
the outpatient setting of a hospital facility, assuming imme- 
diate access to cardiac surgery if necessary and accommo- 
dations for 4 to 6 h of postprocedural observation. The 
statement warned of the relatively high risk of the procedure 
for certain patients, such as the very young and the very old. 
Because survival rates in these groups of the young and old 
were lower than rates for the general population of hospital- 
ized patients, hospital-based procedures were considered to 
be essential. 
In December 1985, a joint statement on ambulatory 
cardiac catheterization was issued by the American College 
of Cardiology (ACC) and the American Heart Association 
(AHA) (2). Both organizations concurred with the recom- 
mendations of the American College of Physicians and 
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further outlined specific conditions under which patients 
should not ordinarily undergo outpatient cardiac catheteriza- 
tion. Their statement also reinforced the position that the 
presence of facilities for postcardiac catheterization obser- 
vation was essential, in addition to assured availability of a 
hospital bed and access to emergency surgery if needed. 
Interim developments. Since promulgation of these poli- 
cies in 1985, several developments have occurred. First, 
there has been a proliferation of cardiac catheterization 
laboratories, with some 1,200 facilities nationwide now 
identified. Second, as the nation responds to cost- 
containment initiatives, some new types of laboratories are 
being presented as less costly than those in the traditional 
setting of a hospital. 
The problem: insufficient data. In 1989, the Office of 
Health Technology Assessment with the assistance of the 
National Center for Health Services Research and Health 
Care Technology Assessment (3) analyzed the experiences 
(some published, some not) of several ambulatory and 
freestanding cardiac catheterization laboratories. The au- 
thors of the analysis summarized a previous literature review 
that had revealed little consensus within the cardiovascular 
community on the use of freestanding catheterization labo- 
ratories. Furthermore, in that review, ambulatory and free- 
standing cardiac catheterization laboratory data were inap- 
propriately compared; the outpatient hospital setting is quite 
different from the freestanding setting, making these two 
environments not comparable. 
In 1986, Kathleen L. Kahn, MD (4) of the Rand Corpo- 
ration had reviewed available reports and expressed her 
concerns about adequate evaluation of outpatient cardiac 
catheterization. Her views were summarized in the Office of 
Health Technology Assessment report (3) as follows: 
“ . . . the lack of data regarding the types and severity of 
pathology in patients studied in the different ambulatory 
settings makes it difficult to assure comparability of the 
populations. Therefore, comparison of mortality and mor- 
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bidity rates from hospital and freestanding settings would 
not provide an accurate picture of the importance of the 
cardiac catheterization venue to the outcome of cardiac 
catheterization”. Despite these and other valid concerns, 
the Office of Health Technology Assessment concluded that 
patients in the freestanding setting enjoy a lower rate of 
complications. 
The Office of Health Technology Assessment report (3) 
also cites the results of one study of interhospital transport 
of patients receiving intraaortic balloon support as indicative 
that this type of highly technical transport is feasible for 
patients who have complications after cardiac catheteriza- 
tion in the freestanding setting. Independent review of this 
article indicates that the Office of Health Technology As- 
sessment has drawn a broader conclusion from this informa- 
tion than the original research suggests. The single institu- 
tion studied had an active cardiac catheterization laboratory 
and a highly trained group of nursing, medical and paramed- 
ical personnel. The requisite ambulance support is specific 
and technical. One must ask the very important question: 
Can the availability of these support services be assured for 
each freestanding facility? 
The authors of the Office of Health Technology Assess- 
ment report (3) readily acknowledge that the National Insti- 
tutes of Health, The American Heart Association, the Amer- 
ican College of Physicians, the American Society of 
Anesthesiologists and the American College of Cardiology 
do not support cardiac catheterization in the freestanding 
setting. The only organization cited in their report that does 
support this setting is the Association for Ambulatory Car- 
diac Catheterization. 
More recently the California Department of Health un- 
dertook a demonstration project with the assistance of 
technical advisory committees to evaluate the safety and 
efficacy of freestanding and mobile cardiac catheterization 
laboratories. In August 1989 it was reported at a public 
hearing that inadequate data had been gathered to assess the 
concept of such laboratories and that the demonstration 
project should continue. 
Cardiologists face the issue of proper referral and treat- 
ment for their patients when cardiac catheterization is indi- 
cated. Because there are few data on the experience of 
patients in alternative settings, it is difficult to provide a 
rational assessment of the specific instances when ambula- 
tory catheterization in a freestanding laboratory is safe and 
efficacious and when it is not. 
Another concern is the lack of quality control of the 
performance of freestanding or mobile cardiac catheteriza- 
tion laboratories. The Joint Commission on Accreditation of 
Health Care Organizations has developed criteria to be used 
to establish safety guidelines in the freestanding setting. 
However, only a small fraction of the existing laboratories 
have met the criteria, and the issues of ongoing supervision 
and review are not addressed. 
Concerns of cardiologists. The ACC and the AHA want to 
assist federal agencies in carefully and adequately evaluating 
the safety and efficacy of freestanding facilities for cardiac 
catheterization and angiography. Toward that goal, the two 
organizations will soon undertake a survey of members and 
nonmembers to estimate the extent of cardiac catheteriza- 
tion procedures being performed and to learn more about the 
types of settings in which they are being performed. The 
survey will also seek to measure the attitudes and opinions 
of cardiologists about the safety and efficacy of performing 
the procedure in outpatient settings (hospital-based, free- 
standing and mobile). Results of the survey will be analyzed 
by the ACUAHA Task Force on Cardiac Catheterization, 
which was formed to reconsider this issue. The recommen- 
dations of the Task Force are expected later this year. 
Summary. As I recently wrote in an editorial in Clinical 
Cardiology, I believe that, although economic issues are of 
great concern, the safety of the patient has to come first (5). 
Pink et al. (6) have indicated that hospital facilities or the 
lack of hospital facilities and nursing staff will often dictate 
the necessity for performing procedures on an outpatient 
basis. However outpatient cardiac catheterization in the 
hospital setting is not the same as outpatient cardiac cathe- 
terization in a freestanding or mobile facility. Because a 
complication rate exists, I strongly believe that cardiac 
catheterization and angiography should be performed in a 
facility where surgical support is immediately available. The 
performance of special procedures (transseptal left heart 
catheterization and coronary angioplasty, for example) in a 
freestanding ambulatory setting is of particular concern. 
However, let me state again that I believe that outpatient 
cardiac catheterization is here to stay. A major reason is the 
increasing need for repeated cardiac catheterization in sev- 
eral groups of patients with cardiac disease, including pa- 
tients with a heart transplant, some patients with arrhythmia 
and patients undergoing coronary recanalization procedures, 
perhaps even patients undergoing valvuloplasty. 
The lack of general guidelines on the characteristics of 
laboratories that can deliver optimal care and the lack of 
definition of patients suitable for cardiac catheterization in 
the various settings plus the inability to assure quality in 
freestanding or mobile outpatient catheterization settings 
leaves me to question their very existence. For these rea- 
sons, I believe it is prudent to proceed slowly and to not rush 
into the development of freestanding or mobile cardiac 
catheterization laboratories until adequate data are available 
to document their safety and efficacy. 
Finally, I emphasize that the cardiologist performing 
catheterization who is contemplating outpatient procedures, 
whether in the hospital or in a freestanding or mobile unit, 
has the responsibility to decide which patients are at low risk 
and can satisfactorily undergo outpatient catheterization. 
The casual acceptance of patients for outpatient catheteriza- 
tion, who have not been adequately evaluated either by the 
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cardiologist performing the procedure or by physicians 
known to the cardiologist, is a risky business. 
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